WASHINGTON — The federal government is spending more money on brand-name drugs for seniors in the Medicare Part D program, even as the number of prescriptions falls, a government watchdog report released Monday concluded.
The analysis, conducted by the Department of Health and Human Services Office of Inspector General, landed in Washington amid talks of radical changes to the Part D program, which typically covers drugs dispensed at a pharmacy.
Nice for you to recognize your own character. Cheers!
Supposed to happen that way. No other choices. Every drug even if it is not an orphan drug will be priced high to maintain the “C” suit lifestyle.